AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14977246 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent‐Adolescent Relationship Education (PARE) Program (experimental education group)
Number of subjects: 0
Study 14977246 — intervention group
Group type: COMPARATOR
Intervention: Attention-control group (traditional didactic teaching)
Number of subjects: 0
Study 10792556 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - transdermal application of continuous 17-beta oestradiol with cyclic medroxyprogesterone acetate tablets every 3rd month for 14 days
Number of subjects: 118
Study 10792556 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - sequential administration of medroxyprogesterone acetate
Number of subjects: 118
Study 10792556 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 118
Study 10792556 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 118
Study 10792556 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - during medroxyprogesterone administration
Number of subjects: 118
Study 9065187 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestrinone 2.5 mg
Number of subjects: 11
Study 9065187 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestrinone 1.25 mg
Number of subjects: 11
Study 2882184 — intervention group
Group type: EXPERIMENTAL
Intervention: Seropositive marrow donors
Number of subjects: 40
Study 2882184 — intervention group
Group type: COMPARATOR
Intervention: Seronegative marrow donors
Number of subjects: 40
Study 29258836 — intervention group
Group type: EXPERIMENTAL
Intervention: Spherical near centred lens (S-CN)
Number of subjects: 150
Study 29258836 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance centred lens (CD)
Number of subjects: 150
Study 29258836 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspherical near centred lens (A-CN)
Number of subjects: 150
Study 29258836 — intervention group
Group type: EXPERIMENTAL
Intervention: All designs
Number of subjects: 150
Study 27449527 — intervention group
Group type: EXPERIMENTAL
Intervention: G + MH intervention (mental health Internet interventions + gambling intervention)
Number of subjects: 280
Study 27449527 — intervention group
Group type: COMPARATOR
Intervention: G‐only intervention (gambling intervention only)
Number of subjects: 280
Study 23754339 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-based sleep education
Number of subjects: 80
Study 24231016 — intervention group
Group type: EXPERIMENTAL
Intervention: Test food containing 300 mg calcium, 150 mg magnesium, and 4.0 g lactulose
Number of subjects: 76
Study 24231016 — intervention group
Group type: COMPARATOR
Intervention: Nonintake control group
Number of subjects: 76
Study 19949010 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention after verbal narrative
Number of subjects: 50
Study 19949010 — intervention group
Group type: COMPARATOR
Intervention: Verbal narrative (control)
Number of subjects: 50
Study 19949010 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 50
Study 19016185 — intervention group
Group type: EXPERIMENTAL
Intervention: Jinniu capsules
Number of subjects: 212
Study 19016185 — intervention group
Group type: COMPARATOR
Intervention: lofexidine
Number of subjects: 212
Study 16170118 — intervention group
Group type: EXPERIMENTAL
Intervention: New foldable monofocal intraocular lens with flexible haptics
Number of subjects: 40
Study 16170118 — intervention group
Group type: COMPARATOR
Intervention: Standard foldable intraocular lens
Number of subjects: 40
Study 14514774 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver iontophoretic catheters
Number of subjects: 268
Study 14514774 — intervention group
Group type: COMPARATOR
Intervention: Control catheters
Number of subjects: 268
Study 11111143 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release twice-daily nifedipine
Number of subjects: 10
Study 11111143 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (without specifying dosage or duration)
Number of subjects: 10
Study 11111143 — intervention group
Group type: COMPARATOR
Intervention: Control (without nifedipine)
Number of subjects: 10
Study 8656243 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone plus prednisone
Number of subjects: 161
Study 8656243 — intervention group
Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 161
Study 1893612 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chloride (100 mmol slow sodium)
Number of subjects: 11
Study 1893612 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 6358370 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 91
Study 6358370 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin and amoxycillin
Number of subjects: 91
Study 29906525 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab 300 mg
Number of subjects: 204
Study 29906525 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 29906525 — intervention group
Group type: COMPARATOR
Intervention: Pooled Tralokinumab
Number of subjects: 204
Study 29882722 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week weighted ball throwing program (2 to 32 ounces), 3 times per week
Number of subjects: 38
Study 29882722 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week weighted ball throwing program
Number of subjects: 38
Study 29882722 — intervention group
Group type: COMPARATOR
Intervention: 5-ounce regulation baseball
Number of subjects: 38
Study 24995890 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive edivoxetine (6-18 mg once daily)
Number of subjects: 131
Study 24995890 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive edivoxetine
Number of subjects: 131
Study 24995890 — intervention group
Group type: COMPARATOR
Intervention: Adjunctive placebo
Number of subjects: 131
Study 22198479 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspired CO₂
Number of subjects: 10
Study 21050498 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon ion radiation therapy (60 Gy E ± 5%)
Number of subjects: 0
Study 21050498 — intervention group
Group type: COMPARATOR
Intervention: Proton radiation therapy (70 Gy E ± 5%)
Number of subjects: 0
Study 21050498 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon ion radiation therapy
Number of subjects: 0
Study 21050498 — intervention group
Group type: COMPARATOR
Intervention: Proton radiation therapy
Number of subjects: 0
Study 17329748 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment for 12 weeks
Number of subjects: 47
Study 17329748 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 12 weeks
Number of subjects: 47
Study 16277771 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (rowed at 55% of maximal aerobic power for 80 min)
Number of subjects: 8
Study 16277771 — intervention group
Group type: COMPARATOR
Intervention: Rest (control group)
Number of subjects: 8
Study 16277771 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 8
Study 12226773 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathy
Number of subjects: 43
Study 12226773 — intervention group
Group type: COMPARATOR
Intervention: Standardised physiotherapy
Number of subjects: 43
Study 10647571 — intervention group
Group type: EXPERIMENTAL
Intervention: Locked double‐plating construct
Number of subjects: 12
Study 10647571 — intervention group
Group type: COMPARATOR
Intervention: Standard double‐plating construct
Number of subjects: 12
Study 9083709 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro (immediately before each meal)
Number of subjects: 631
Study 9083709 — intervention group
Group type: COMPARATOR
Intervention: Regular human insulin (30 to 45 minutes before eating)
Number of subjects: 631
Study 1362497 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg ranitidine
Number of subjects: 47
Study 1362497 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg cimetidine
Number of subjects: 47
Study 1362497 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg famotidine
Number of subjects: 47
Study 1362497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 3993320 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (22.5 mg)
Number of subjects: 21
Study 3993320 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-containing bupivacaine (20 mg)
Number of subjects: 21
Study 3993320 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracaine (15 mg)
Number of subjects: 21
Study 30129517 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised Structured Aerobic Exercise Training (SSAET) program, routine medication, and dietary plan for 25 weeks.
Number of subjects: 102
Study 30129517 — intervention group
Group type: COMPARATOR
Intervention: Routine medication and dietary plan for 25 weeks (Control group).
Number of subjects: 102
Study 27154904 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week aerobic exercise intervention (3 days/week, combined aerobic and resistance exercise at 70% heart rate reserve)
Number of subjects: 76
Study 25589316 — intervention group
Group type: COMPARATOR
Intervention: Basic therapy including antibiotics, vessels extending drugs, neuroprotective and detoxification facilities.
Number of subjects: 60
Study 25589316 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoflavin 10 ml 0.9% NaCl 200 ml for 10 days, followed by 2 tablets 2 times a day orally for 1 month in addition to basic therapy.
Number of subjects: 60
Study 22621779 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquacel Ag Hydrofiber dressing
Number of subjects: 112
Study 22621779 — intervention group
Group type: COMPARATOR
Intervention: Common dressing
Number of subjects: 112
Study 20837917 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous T3 as Triostat (n=98)
Number of subjects: 193
Study 20837917 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=95)
Number of subjects: 193
Study 19061712 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor (G-CSF) administered at 10 microg/kg SC for 5 days, followed by leukapheresis and randomized double-blinded intracoronary infusion of CD133+ or unselected cells after 3 months
Number of subjects: 20
Study 19061712 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving unselected cells (details not specified)
Number of subjects: 20
Study 16548348 — intervention group
Group type: EXPERIMENTAL
Intervention: QYJD
Number of subjects: 60
Study 16548348 — intervention group
Group type: COMPARATOR
Intervention: Danazol
Number of subjects: 60
Study 16548348 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 60
Study 16548348 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 60
Study 12818601 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimac wires
Number of subjects: 50
Study 12818601 — intervention group
Group type: COMPARATOR
Intervention: Arch bars
Number of subjects: 50
Study 10661755 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous identical bilateral movements
Number of subjects: 12
Study 10661755 — intervention group
Group type: COMPARATOR
Intervention: Unilateral performance tests with the hemiplegic arm
Number of subjects: 12
Study 8651085 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (40 mg subcutaneously per day for 25 days, n=43)
Number of subjects: 103
Study 8651085 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment, n=60)
Number of subjects: 103
Study 1521210 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose prednisone (263 patients)
Number of subjects: 523
Study 1521210 — intervention group
Group type: COMPARATOR
Intervention: Placebo (260 patients)
Number of subjects: 523
Study 28983968 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized 6-mercaptopurine increments (stepwise increments of additional 25 mg/m2/day starting on days 50 and/or 71)
Number of subjects: 788
Study 28983968 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (oral 6-mercaptopurine 25 mg/m2/day from days 30 to 85)
Number of subjects: 788
Study 28983968 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized 6-mercaptopurine increments
Number of subjects: 788
Study 26937858 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (n = 61)
Number of subjects: 123
Study 26937858 — intervention group
Group type: COMPARATOR
Intervention: Early parenteral nutrition (n = 62)
Number of subjects: 123
Study 24958315 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intra-articular infusion anesthesia
Number of subjects: 214
Study 24958315 — intervention group
Group type: COMPARATOR
Intervention: Epidural infusion anesthesia
Number of subjects: 214
Study 21105289 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LV) administered in a fixed dose schedule over 6 days
Number of subjects: 106
Study 21105289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 21105289 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LV)
Number of subjects: 106
Study 18310870 — intervention group
Group type: EXPERIMENTAL
Intervention: AFB 84%
Number of subjects: 12
Study 18310870 — intervention group
Group type: COMPARATOR
Intervention: Bicarbonate Dialysis (BD)
Number of subjects: 12
Study 18310870 — intervention group
Group type: COMPARATOR
Intervention: Comparison of AFB 84% and BD
Number of subjects: 12
Study 15696988 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional injections of 2% zinc sulfate solution
Number of subjects: 72
Study 15696988 — intervention group
Group type: COMPARATOR
Intervention: Meglumine antimonate (Glucantime)
Number of subjects: 72
Study 12789463 — intervention group
Group type: EXPERIMENTAL
Intervention: Californium-252 (252Cf)
Number of subjects: 227
Study 12789463 — intervention group
Group type: COMPARATOR
Intervention: Conventional gamma radiation
Number of subjects: 227
Study 10591351 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid (60 mg methylprednisolone IM and 12 mg dexamethasone IV)
Number of subjects: 28
Study 10591351 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 28
Study 9088130 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvesical removal of the adenoma (TRA, Group 1, n = 65)
Number of subjects: 180
Study 9088130 — intervention group
Group type: EXPERIMENTAL
Intervention: TURP (Group 2, n = 51)
Number of subjects: 180
Study 9088130 — intervention group
Group type: COMPARATOR
Intervention: Doxazosin therapy (Group 3, n = 64)
Number of subjects: 180
Study 1651859 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline 1.25 mg
Number of subjects: 20
Study 1651859 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 20
Study 6406700 — intervention group
Group type: EXPERIMENTAL
Intervention: D 25%, CAA 4.25% (Group 1)
Number of subjects: 120
Study 6406700 — intervention group
Group type: EXPERIMENTAL
Intervention: D 35%, CAA 4.25% (Group 2)
Number of subjects: 120
Study 6406700 — intervention group
Group type: EXPERIMENTAL
Intervention: D 25%, CAA 21.3% (Group 3)
Number of subjects: 120
Study 6406700 — intervention group
Group type: EXPERIMENTAL
Intervention: D 35%, CAA 21.3% (Group 4)
Number of subjects: 120
Study 6406700 — intervention group
Group type: EXPERIMENTAL
Intervention: D 35%, CAA 2.75% (Group 5)
Number of subjects: 120
Study 6406700 — intervention group
Group type: EXPERIMENTAL
Intervention: D 25%, CAA 2.75% (Group 6)
Number of subjects: 120
Study 6406700 — intervention group
Group type: EXPERIMENTAL
Intervention: D 35%, CAA 4.25% (Group 7)
Number of subjects: 120
Study 6406700 — intervention group
Group type: EXPERIMENTAL
Intervention: D 25%, CAA 4.25% (Group 8)
Number of subjects: 120
Study 31609942 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimaxillary and chin orthognathic surgery
Number of subjects: 20
Study 29340854 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 sessions of fractionated thulium laser treatment
Number of subjects: 10
Study 29340854 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-laser treatment application of growth factor (GF) solution
Number of subjects: 10
Study 26926656 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive airway pressure therapy
Number of subjects: 416
Study 26926656 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 416
Study 26926656 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive airway pressure therapy (adherent group)
Number of subjects: 416
Study 25209521 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozenoxacin 1% cream
Number of subjects: 0
Study 25209521 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozenoxacin 2% cream
Number of subjects: 0
Study 25209521 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26845802 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam dressing in NPWT
Number of subjects: 0
Study 26845802 — intervention group
Group type: COMPARATOR
Intervention: Gauze dressing in NPWT
Number of subjects: 0
Study 20301819 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter perpendicular to the nerve
Number of subjects: 50
Study 20301819 — intervention group
Group type: COMPARATOR
Intervention: Catheter parallel to the nerve
Number of subjects: 50
Study 20301819 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 16231362 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate
Number of subjects: 41
Study 16231362 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and Vitamin D
Number of subjects: 41
Study 16231362 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 41
Study 12678340 — intervention group
Group type: EXPERIMENTAL
Intervention: NaP (oral sodium phosphate)
Number of subjects: 72
Study 12678340 — intervention group
Group type: COMPARATOR
Intervention: PEG (polyethylene glycol electrolyte lavage solution)
Number of subjects: 72
Study 10740542 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopexamine 1.0 mg kg‐1 over 5 min, followed by an infusion of 2 micrograms kg‐1 min‐1
Number of subjects: 50
Study 10740542 — intervention group
Group type: COMPARATOR
Intervention: Saline (equal volume to dopexamine)
Number of subjects: 50
Study 8598592 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 71
Study 8598592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 1430505 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrices containing fluoride at levels of 1250, 2500, and 5000 ppm
Number of subjects: 520
Study 1430505 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrices containing 15 mg percent xylitol
Number of subjects: 520
Study 1430505 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 520
Study 3972929 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotherapy (6 standardized sessions, one hourly session per week)
Number of subjects: 48
Study 3972929 — intervention group
Group type: COMPARATOR
Intervention: Hypnotherapy
Number of subjects: 48
Study 31855909 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week single-legged decline-squat exercise
Number of subjects: 34
Study 31855909 — intervention group
Group type: COMPARATOR
Intervention: 12-week single-legged decline-squat exercise + weekly session of ESWT for 6 weeks
Number of subjects: 34
Study 29940797 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-delivered mindfulness-based cognitive therapy
Number of subjects: 8
Study 27206513 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 54
Study 27206513 — intervention group
Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 54
Study 26958009 — intervention group
Group type: EXPERIMENTAL
Intervention: Early amniotomy
Number of subjects: 214
Study 26958009 — intervention group
Group type: COMPARATOR
Intervention: Conservation of membranes (Control)
Number of subjects: 214
Study 23877988 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin alone or in combination with glargine insulin
Number of subjects: 90
Study 23877988 — intervention group
Group type: COMPARATOR
Intervention: Basal bolus insulin regimen (glargine and lispro) plus supplemental doses of lispro
Number of subjects: 90
Study 21283736 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Hospital (Arm I)
Number of subjects: 83
Study 21283736 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (Arm II)
Number of subjects: 83
Study 20108652 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (Bellissima)
Number of subjects: 20
Study 20108652 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 20
Study 16426094 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5-20 mg/day)
Number of subjects: 431
Study 16426094 — intervention group
Group type: COMPARATOR
Intervention: Lithium (serum concentration 0.6 to 1.2 mEq/L)
Number of subjects: 431
Study 15450048 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (OS) for 3 months
Number of subjects: 91
Study 15450048 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 91
Study 11575169 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom mind/body wellness intervention
Number of subjects: 243
Study 11575169 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 243
Study 9600501 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg)
Number of subjects: 202
Study 9600501 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg)
Number of subjects: 202
Study 9600501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 8010268 — intervention group
Group type: EXPERIMENTAL
Intervention: SHARE fast spin-echo imaging technique
Number of subjects: 50
Study 8010268 — intervention group
Group type: COMPARATOR
Intervention: Conventional long-repetition-time spin-echo imaging
Number of subjects: 50
Study 2511590 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-session smoking prevention program
Number of subjects: 608
Study 1094565 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrithioxine (Encephabol)
Number of subjects: 44
Study 1094565 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 44
Study 31853103 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone 0.5mg/kg in 5ml
Number of subjects: 64
Study 31853103 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5ml 0.9% saline)
Number of subjects: 64